cefoperazone has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, QJ; Yu, ZP; Zeng, QQ; Zhang, QY; Zheng, XW | 1 |
| Choe, KJ; Gottesman, MM; Hong, IG; Kim, HS; Kim, WH; Kim, YI; Lee, SK; Lim, KH; Park, JG; Tsuruo, T | 1 |
2 other study(ies) available for cefoperazone and Liver Neoplasms
| Article | Year |
|---|---|
Primary hepatic actinomycosis mimicking liver tumour.
Topics: Actinomyces; Actinomycosis; Adult; Anti-Bacterial Agents; Cefoperazone; Diagnosis, Differential; Humans; Liver Diseases; Liver Neoplasms; Male; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Carrier Proteins; Cefoperazone; Ceftriaxone; Doxorubicin; Drug Resistance; Drug Synergism; Gene Expression; Humans; Immunohistochemistry; Liver Neoplasms; Membrane Glycoproteins; Neoplasm Proteins; Quinidine; RNA, Messenger; Trifluoperazine; Tumor Cells, Cultured; Verapamil | 1994 |